Interventional Cardiology: Implantable Pacemaker Products
Interventional Cardiology: Implantable Pacemaker Products
$4,750.00
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries.
Publisher: Meddevicetracker
- Highlights
- Description
- Contents
Topics covered include:
- An overview of implantable pacemaker products, including: single chamber, dual-chamber, and cardiac resynchronization therapy pacemakers(CRT-P, or biventricular
pacemakers). - Selected statistics for cardiac rhythm disorders and heart failure for the major regions covered in this report (eg the US, five major EU markets, and Japan).
- Global and country/region-specific market forecasts, including forecasts by product segment.
- Competitive analyses by country/region.
- Discussion of key drivers and limiters impacting the major product segments.
- A review of emerging technologies which could impact sales of existing devices.
Report Highlights:
Total unit sales for implantable pacemaker products are steadily increasing due to a number of factors, including: the increasing prevalence of CVD and cardiac rhythm disorders, advances in CVD diagnostics, and demand for cardiac rhythm disorder therapies in emerging markets.
In 2017, dual-chamber pacemakers accounted for the majority of worldwide implantable pacemaker product sales. Dual-chamber pacemakers are projected to account for the majority of total product sales throughout the forecast period covered by this report (2017-23).
The global market for implantable pacemaker products is anticipated to increase ata CAGRof S.1%during the forecast period, reaching approximately $5,324.2m in total product sales by 2023.
The US was the largest market based on total implantable pacemaker product sales in 2017. Sales of these products to the US accounted for approximately 35.6% of total product sales in 2017.
Implantable pacemaker insertion is the primary treatment for certain cardiac rhythm disorders, specifically bradyarrhythmia. lf left untreated, severe forms of bradyarrhythmia can cause cardiac arrest and death. While external pacemakers may also be used to treat bradyarrhythmia, they are not a convenient long-term solution.
Overview
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the implantable pacemaker products market. Implantable pacemaker products covered by this report include:
- single-chamber pacemakers, including leadless pacemakers
- dual-chamber pacemakers
- biventricular pacemakers, also known as cardiac resynchronization therapy pacemakers (CRT-P)
The global market for implantable pacemaker products is anticipated to see moderate, single-digit growth throughout the forecast period covered by this analysis (2017-23). Growth in unit sales is being driven by the increasing prevalence of cardiovascular disease, which is the leading cause of death globally, responsible for over 17 million deaths annually. Global product sales are projected to expand at a compound annual growth rate (CAGR) of 5.1% during the 2017-23 forecast, increasing from approximately $3,940.3m in 2017 to an estimated $5,324.2m in 2023.
Table of Contents
Executive Summary …………………………………………………………………………………………………… ES‐1
i. Cardiac rhythm disorders overview………………………………………………………………………..ES‐1
ii. Global implantable pacemaker products market …………………………………………………….ES‐1
a. Market drivers and limiters……………………………………………………………………….ES‐3
b. Device segment insights …………………………………………………………………………..ES‐4
c. Technology trends……………………………………………………………………………………ES‐4
d. Market leaders………………………………………………………………………………………..ES‐5
e. Competitive strategies……………………………………………………………………………..ES‐5
f. Emerging competition ………………………………………………………………………………ES‐5
iii. Methodology……………………………………………………………………………………………………..ES‐6
Exhibit ES‐1: Implantable pacemaker products, global market forecast, 2017‐23 ………………………ES‐2
Exhibit ES‐2: Global implantable pacemaker products market, share by country/region, 2017 ……ES‐3
Exhibit ES‐3: Drivers and limiters of growth – implantable pacemaker products………………………..ES‐4
1. Cardiac Rhythm Disorders Overview …………………………………………………………………………… 1‐1
1.1 Sick sinus syndrome…………………………………………………………………………………………… 1‐4
1.2 Bradycardia ………………………………………………………………………………………………………. 1‐4
1.3 Heart block……………………………………………………………………………………………………….. 1‐5
1.4 Tachycardia ………………………………………………………………………………………………………. 1‐6
1.5 Atrial fibrillation ………………………………………………………………………………………………… 1‐7
1.6 Heart failure ……………………………………………………………………………………………………… 1‐8
1.7 Diagnosis and treatment…………………………………………………………………………………… 1‐11
1.8 Bibliography ……………………………………………………………………………………………………. 1‐12
Exhibit 1‐1: Estimated prevalence rates of conduction disorders and cardiac arrhythmias, based on health care utilization, select countries………………………………………………….. 1‐2
Exhibit 1‐2: Estimated number of hospital discharges for conduction disorders and cardiac arrhythmias, select countries……………………………………………………………………………… 1‐3
Exhibit 1‐3: Estimated prevalence of atrial fibrillation, select countries, 2018……………………………. 1‐8
Exhibit 1‐4: Estimated prevalence of chronic heart failure, select countries, 2018……………………… 1‐9
Exhibit 1‐5: Estimated prevalence of acute decompensated heart failure, select countries, 2018. 1‐10
2. Pacemaker Devices ………………………………………………………………………………………………….. 2‐1
2.1 Implantable pacemaker systems…………………………………………………………………………. 2‐2
2.1.1 Implantable pacemaker products………………………………………………………….. 2‐3
2.1.2 Developments in implantable pacemaker technology ……………………………… 2‐5
2.2 Temporary pacing systems …………………………………………………………………………………. 2‐7
2.2.1 External pacemaker products……………………………………………………………….. 2‐8
2.3 Bibliography ……………………………………………………………………………………………………… 2‐9
Exhibit 2‐1: NBG code for implantable pacemaker systems……………………………………………………… 2‐3
Exhibit 2‐2: Selected implantable pacemakers and manufacturers…………………………………………… 2‐4
Exhibit 2‐3: EBR Systems’ WiSE CRT system …………………………………………………………………………… 2‐7
Exhibit 2‐4: Selected external pacemakers and manufacturers………………………………………………… 2‐8
3. Implantable Pacemaker Products Market…………………………………………………………………….. 3‐1
3.1 Global market insights……………………………………………………………………………………….. 3‐1
3.1.1 Market value………………………………………………………………………………………. 3‐2
3.1.2 Technology trends ………………………………………………………………………………. 3‐6
3.1.3 Market drivers and limiters ………………………………………………………………….. 3‐7
3.1.4 Implantable pacemaker products overview ……………………………………………. 3‐8
3.1.5 Market leaders……………………………………………………………………………………. 3‐9
3.1.6 Competitive strategies……………………………………………………………………….. 3‐10
3.1.7 Emerging competition …………………………………………………………………………. ‐10
3.2 Global competitors ………………………………………………………………………………………….. 3‐11
3.3 Market forecast……………………………………………………………………………………………….. 3‐13
3.3.1 Market forecast: US …………………………………………………………………………… 3‐13
3.3.2 Market forecast: five major EU markets……………………………………………….. 3‐17
3.3.3 Market forecast: Japan ………………………………………………………………………. 3‐21
3.3.4 Market forecast: rest of the world ………………………………………………………. 3‐24
3.4 Bibliography ……………………………………………………………………………………………………. 3‐29
Exhibit 3‐1: Implantable pacemaker products, global market forecast ($m), 2017‐23…………………. 3‐2
Exhibit 3‐2: Implantable pacemaker products, global market forecast ($m) by product type, 2017‐23 …………………………………………………………………………………. 3‐3
Exhibit 3‐3: Global implantable pacemaker product sales, share by product segment, 2017……….. 3‐4
Exhibit 3‐4: Global implantable pacemaker products market, share by country/region, 2017 ……… 3‐5
Exhibit 3‐5: Global implantable pacemaker product sales, combined market forecast ($m), by country/region, 2017‐23…………………………………………………………………………………… 3‐6
Exhibit 3‐6: Drivers and limiters of market growth – implantable pacemaker products………………. 3‐8
Exhibit 3‐7: Implantable pacemaker products, share by product type, 2017 and 2023 ……………….. 3‐9
Exhibit 3‐8: Global implantable pacemaker products market, share by supplier, 2017 ……………… 3‐13
Exhibit 3‐9: US Implantable pacemakers, procedure volumes forecast (000s), 2017‐23…………….. 3‐15
Exhibit 3‐10: US Implantable pacemaker product sales, market forecast ($m) by product type, 2017‐23 ……………………………………………………………………………………. 3‐16
Exhibit 3‐11: US implantable pacemaker products market, share by supplier, 2017 …………………. 3‐17
Exhibit 3‐12: 5EU Implantable pacemakers, procedure volumes forecast (000s), 2017‐23 ………… 3‐19
Exhibit 3‐13: 5EU Implantable pacemaker product sales, market forecast ($m) by product type, 2017‐23………………………………………………………………………………………………………… 3‐20
Exhibit 3‐14: 5EU implantable pacemaker products market, share by supplier, 2017 ……………….. 3‐21
Exhibit 3‐15: Japanese Implantable pacemakers, procedure volumes forecast (000s), 2017‐23 …. 3‐22
Exhibit 3‐16: Japanese Implantable pacemaker product sales, market forecast ($m) by product type, 2017‐23 ……………………………………………………………………………………. 3‐23
Exhibit 3‐17: Japanese implantable pacemaker products market, share by supplier, 2017 ………… 3‐24
Exhibit 3‐18: RoW Implantable pacemaker product sales, market forecast ($m) by product type, 2017‐23 ……………………………………………………………………………………. 3‐27
Exhibit 3‐19: RoW implantable pacemaker products market, share by supplier, 2017 ………………. 3‐28
Appendix: Company Listing………………………………………………………………………………………………….. A‐1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the